| Drug Name | riociguat |
|---|---|
| Other Drug Names | BAY 63-2521 |
| Chemical Name | methyl N-(4,6-diamino-2-{1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl}pyrimidin-5-yl)-N-methylcarbamate |
| Formula | C20H19FN8O2 |
| Mol. Wt. | 422.4221 |
| CAS No. | 625115-55-1 |
| UNII | RU3FE2Y4XI |
| Target-based Actions | Guanylate cyclase stimulator |
| ATC Codes | C02KX05 |
| Highest Status | 2013年批准上市 |
| Originator Company | Bayer HealthCare Pharmaceuticals, Inc. |
| Structure |
 |